{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:20:06Z","timestamp":1789611606891,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Group B Streptococcus (GBS) is the leading cause of invasive neonatal infection worldwide. In high-income countries mortality rates are 4\u201310%, and among survivors of GBS meningitis 30\u201350% have neurodevelopmental impairments.\u00a0We hypothesized that invasive GBS infection was associated with increased risk of infant mortality and cerebral palsy (CP).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>All children born alive in Norway during 1996\u20132012 were included. Data were collected from three national registers. Invasive GBS infection during infancy was categorized into early-onset disease (EOD), late-onset disease\u00a0(LOD), and very late-onset disease (VLOD). Primary outcomes were infant mortality and CP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Invasive GBS infection was diagnosed in 625 children (incidence: 0.62 per 1000 live births; 95% confidence interval (CI): 0.57\u20130.67). The incidence of EOD was 0.41 (0.37\u20130.45), of LOD 0.20 (0.17\u20130.23), and of VLOD 0.012 (0.007\u20130.021). The annual incidence of LOD increased slightly. Among infected infants, 44 (7%) died (odds ratio (OR): 24.5; 95% CI: 18.0\u201333.3 compared with the background population). Among survivors, 24 (4.1%) children were later diagnosed with CP, compared with 1887 (0.19%) in the background population (OR: 22.9; 95% CI: 15.1\u201334.5).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Despite a relatively low incidence of invasive GBS infection in Norway, the risk of death and CP remains high. Improvements in prevention strategies are needed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Impact<\/jats:title><jats:p><jats:list list-type=\"bullet\"><jats:list-item><jats:p>During the first decade of the twenty-first century, invasive GBS disease in infancy is still associated with high mortality.<\/jats:p><\/jats:list-item><jats:list-item><jats:p>Despite the overall low incidence of invasive GBS disease, the incidence of LOD increased during the study period.<\/jats:p><\/jats:list-item><jats:list-item><jats:p>The finding that invasive GBS infection in the neonatal period or during infancy is associated with an excess risk of CP, comparable to the risk following moderate preterm birth and moderate low Apgar scores, adds to the existing literature.<\/jats:p><\/jats:list-item><jats:list-item><jats:p>The results of this study emphasize the importance of adhering to guidelines and the need for better prevention strategies.<\/jats:p><\/jats:list-item><\/jats:list><\/jats:p><\/jats:sec>","DOI":"10.1038\/s41390-020-1092-2","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T09:04:02Z","timestamp":1596013442000},"page":"1541-1548","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Incidence of invasive Group B Streptococcal infection and the risk of infant death and cerebral palsy: a Norwegian Cohort Study"],"prefix":"10.1038","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3027-4497","authenticated-orcid":false,"given":"Maren","family":"Mynarek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solveig","family":"Bjellmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stian","family":"Lydersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan E.","family":"Afset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guro L.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torstein","family":"Vik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,29]]},"reference":[{"key":"1092_CR1","doi-asserted-by":"publisher","first-page":"S160","DOI":"10.1093\/cid\/cix656","volume":"65","author":"L Madrid","year":"2017","unstructured":"Madrid, L. et al. Infant group B streptococcal disease incidence and serotypes worldwide: systematic review and meta-analyses. Clin. Infect. Dis. 65, S160\u2013S172 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"1092_CR2","doi-asserted-by":"publisher","first-page":"S200","DOI":"10.1093\/cid\/cix664","volume":"65","author":"AC Seale","year":"2017","unstructured":"Seale, A. C. et al. Estimates of the burden of group B streptococcal disease worldwide for pregnant women, stillbirths, and children. Clin. Infect. Dis. 65, S200\u2013S219 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"1092_CR3","doi-asserted-by":"publisher","first-page":"S190","DOI":"10.1093\/cid\/cix663","volume":"65","author":"M Kohli-Lynch","year":"2017","unstructured":"Kohli-Lynch, M. et al. Neurodevelopmental impairment in children after group B streptococcal disease worldwide: systematic review and meta-analyses. Clin. Infect. Dis. 65, S190\u2013S199 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"1092_CR4","unstructured":"Heath, P. T. & Jardine, L. A. Neonatal infections: group B streptococcus. BMJ Clin. Evid. 2014, 0323 (2014)."},{"key":"1092_CR5","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1093\/cid\/cix654","volume":"65","author":"K Le Doare","year":"2017","unstructured":"Le Doare, K. et al. Intrapartum antibiotic chemoprophylaxis policies for the prevention of group B streptococcal disease worldwide: systematic review. Clin. Infect. Dis. 65, S143\u2013S151 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"1092_CR6","doi-asserted-by":"crossref","unstructured":"Nanduri, S. A. et al. Epidemiology of invasive early-onset and late-onset group B streptococcal disease in the united states, 2006 to 2015: multistate laboratory and population-based surveillance. JAMA Pediatr.\u00a0 173, 224\u2013233 (2019).","DOI":"10.1001\/jamapediatrics.2018.4826"},{"key":"1092_CR7","doi-asserted-by":"crossref","unstructured":"Zimmermann, P. & Curtis, N. Effect of intrapartum antibiotics on the intestinal microbiota of infants: a systematic review. Arch. Dis. Child Fetal Neonatal Ed. (2019).","DOI":"10.1136\/archdischild-2018-316659"},{"key":"1092_CR8","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.eimc.2013.09.012","volume":"32","author":"T Juncosa-Morros","year":"2014","unstructured":"Juncosa-Morros, T. et al. Streptococcus agalactiae late-onset neonatal infections in Barcelona (1996\u20132010). Enferm. Infecc. Microbiol. Clin. 32, 574\u2013578 (2014).","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"1092_CR9","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1093\/cid\/cix896","volume":"66","author":"AS Romain","year":"2018","unstructured":"Romain, A. S. et al. Clinical and laboratory features of group B streptococcus meningitis in infants and newborns: study of 848 cases in France, 2001\u20132014. Clin. Infect. Dis. 66, 857\u2013864 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"1092_CR10","doi-asserted-by":"publisher","first-page":"7744","DOI":"10.4081\/idr.2018.7744","volume":"10","author":"E Vergadi","year":"2018","unstructured":"Vergadi, E. et al. Changes in the incidence and epidemiology of neonatal group B Streptococcal disease over the last two decades in Crete, Greece. Infect. Dis. Rep. 10, 7744 (2018).","journal-title":"Infect. Dis. Rep."},{"key":"1092_CR11","doi-asserted-by":"publisher","first-page":"e361","DOI":"10.1542\/peds.2012-1231","volume":"131","author":"A Berardi","year":"2013","unstructured":"Berardi, A. et al. Group B streptococcus late-onset disease: 2003\u20132010. Pediatrics 131, e361\u2013e368 (2013).","journal-title":"Pediatrics"},{"key":"1092_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1473-3099(18)30555-3","volume":"19","author":"CP O\u2019Sullivan","year":"2019","unstructured":"O\u2019Sullivan, C. P. et al. Group B streptococcal disease in UK and Irish infants younger than 90 days, 2014\u201315: a prospective surveillance study. Lancet Infect. Dis. 19, 83\u201390 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"1092_CR13","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/dmcn.13341","volume":"59","author":"SJ Hollungt","year":"2017","unstructured":"Hollungt, S. J. et al. Completeness and correctness of cerebral palsy diagnoses in two health registers: implications for estimating prevalence. Dev. Med. Child Neurol. 59, 402\u2013406 (2017).","journal-title":"Dev. Med. Child Neurol."},{"key":"1092_CR14","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.ejpn.2018.05.001","volume":"22","author":"SJ Hollung","year":"2018","unstructured":"Hollung, S. J. et al. Decreasing prevalence and severity of cerebral palsy in Norway among children born 1999 to 2010 concomitant with improvements in perinatal health. Eur. J. Paediatr. Neurol. 22, 814\u2013821 (2018).","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"1092_CR15","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1017\/S0012162200001511","volume":"42","author":"Surveillance of Cerebral Palsy in Europe.","year":"2000","unstructured":"Surveillance of Cerebral Palsy in Europe. Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Surveillance of Cerebral Palsy in Europe (SCPE). Dev. Med. Child Neurol. 42, 816\u2013824 (2000).","journal-title":"Dev. Med. Child Neurol."},{"key":"1092_CR16","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1469-8749.1997.tb07414.x","volume":"39","author":"R Palisano","year":"1997","unstructured":"Palisano, R. et al. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev. Med. Child Neurol. 39, 214\u2013223 (1997).","journal-title":"Dev. Med. Child Neurol."},{"key":"1092_CR17","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1017\/S0012162206001162","volume":"48","author":"AC Eliasson","year":"2006","unstructured":"Eliasson, A. C. et al. The Manual Ability Classification System (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability. Dev. Med. Child Neurol. 48, 549\u2013554 (2006).","journal-title":"Dev. Med. Child Neurol."},{"key":"1092_CR18","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/dmcn.12866","volume":"58","author":"D Virella","year":"2016","unstructured":"Virella, D. et al. Classification systems of communication for use in epidemiological surveillance of children with cerebral palsy. Dev. Med. Child Neurol. 58, 285\u2013291 (2016).","journal-title":"Dev. Med. Child Neurol."},{"key":"1092_CR19","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1034\/j.1600-0412.2000.079006440.x","volume":"79","author":"R Skjaerven","year":"2000","unstructured":"Skjaerven, R., Gjessing, H. K. & Bakketeig, L. S. Birthweight by gestational age in Norway. Acta Obstet. Gynecol. Scand. 79, 440\u2013449 (2000).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"1092_CR20","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1080\/00949655.2011.579969","volume":"82","author":"S Lydersen","year":"2012","unstructured":"Lydersen, S., Langaas, M. & Bakke, O. The exact unconditional z-pooled test for equality of two binomial probabilities: optimal choice of the Berger and Boos confidence coefficient. J. Stat. Comput. Simul. 82, 1311\u20131316 (2012).","journal-title":"J. Stat. Comput. Simul."},{"key":"1092_CR21","doi-asserted-by":"crossref","unstructured":"Fagerland, M., Lydersen, S., & Laake, P. Statistical Analysis of Contingency Tables (Chapman & Hall\/CRC, 2017).","DOI":"10.1201\/9781315374116"},{"key":"1092_CR22","doi-asserted-by":"publisher","first-page":"F85","DOI":"10.1136\/adc.2007.119958","volume":"93","author":"X Carbonell-Estrany","year":"2007","unstructured":"Carbonell-Estrany, X., Figueras-Aloy, J., Salcedo-Abizanda, S. & de la Rosa-Fraile, M. Probable early-onset group B streptococcal neonatal sepsis: a serious clinical condition related to intrauterine infection. Arch. Dis. Child. 93, F85\u2013F89 (2007).","journal-title":"Arch. Dis. Child."},{"key":"1092_CR23","doi-asserted-by":"crossref","unstructured":"Hajdu, A. et al. Unexpected increase in case fatality of invasive group B streptococcal infections in infants in Norway, January\u2013July 2006. Euro. Surveill. 11, E060727.060722 (2006).","DOI":"10.2807\/esw.11.30.03010-en"},{"key":"1092_CR24","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/archdischild-2017-314642","volume":"104","author":"KT Yeo","year":"2019","unstructured":"Yeo, K. T. et al. Long-term outcomes after group B streptococcus infection: a cohort study. Arch. Dis. Child 104, 172\u2013178 (2019).","journal-title":"Arch. Dis. Child"},{"key":"1092_CR25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nri2075","volume":"7","author":"O Levy","year":"2007","unstructured":"Levy, O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 7, 379\u2013390 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"1092_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1046\/j.1440-1789.2002.00438.x","volume":"22","author":"P Rezaie","year":"2002","unstructured":"Rezaie, P. & Dean, A. Periventricular leukomalacia, inflammation and white matter lesions within the developing nervous system. Neuropathology 22, 106\u2013132 (2002).","journal-title":"Neuropathology"},{"key":"1092_CR27","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1093\/cid\/cix662","volume":"65","author":"CJ Tann","year":"2017","unstructured":"Tann, C. J. et al. Neonatal encephalopathy with group B streptococcal disease worldwide: systematic review, investigator group datasets, and meta-analysis. Clin. Infect. Dis. 65, S173\u2013S189 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"1092_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1203\/00006450-199707000-00001","volume":"42","author":"O Dammann","year":"1997","unstructured":"Dammann, O. & Leviton, A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr. Res. 42, 1\u20138 (1997).","journal-title":"Pediatr. Res."},{"issue":"Suppl. 3","key":"1092_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/dmcn.12723","volume":"57","author":"B Fleiss","year":"2015","unstructured":"Fleiss, B. et al. Inflammation-induced sensitization of the brain in term infants. Dev. Med. Child Neurol. 57(Suppl. 3), 17\u201328 (2015).","journal-title":"Dev. Med. Child Neurol."},{"key":"1092_CR30","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1017\/S001216220500112X","volume":"47","author":"M Bax","year":"2005","unstructured":"Bax, M. et al. Proposed definition and classification of cerebral palsy, April 2005. Dev. Med. Child Neurol. 47, 571\u2013576 (2005).","journal-title":"Dev. Med. Child Neurol."},{"key":"1092_CR31","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.jpeds.2015.02.014","volume":"166","author":"D Tibussek","year":"2015","unstructured":"Tibussek, D. et al. Late-onset group B streptococcal meningitis has cerebrovascular complications. J. Pediatr. 166, 1187\u20131192 (2015).","journal-title":"J. Pediatr."},{"key":"1092_CR32","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.pediatrneurol.2010.11.002","volume":"44","author":"MI Hernandez","year":"2011","unstructured":"Hernandez, M. I. et al. Stroke patterns in neonatal group B streptococcal meningitis. Pediatr. Neurol. 44, 282\u2013288 (2011).","journal-title":"Pediatr. Neurol."},{"key":"1092_CR33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1542\/peds.77.2.217","volume":"77","author":"ER Wald","year":"1986","unstructured":"Wald, E. R. et al. Long-term outcome of group B streptococcal meningitis. Pediatrics 77, 217\u2013221 (1986).","journal-title":"Pediatrics"},{"key":"1092_CR34","unstructured":"Levene, M. & Chervenak, F. Fetal and Neonatal Neurology and Neurosurgery, p. 587 (Elsevier, 2009)."},{"key":"1092_CR35","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/apa.13070","volume":"104","author":"J Luthander","year":"2015","unstructured":"Luthander, J., Bennet, R., Giske, C. G., Nilsson, A. & Eriksson, M. The aetiology of paediatric bloodstream infections changes after pneumococcal vaccination and group B streptococcus prophylaxis. Acta Paediatr. 104, 933\u2013939 (2015).","journal-title":"Acta Paediatr."},{"key":"1092_CR36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/ajo.12378","volume":"56","author":"BA Darlow","year":"2016","unstructured":"Darlow, B. A., Voss, L., Lennon, D. R. & Grimwood, K. Early-onset neonatal group B streptococcus sepsis following national risk-based prevention guidelines. Aust. N. Z. J. Obstet. Gynaecol. 56, 69\u201374 (2016).","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"1092_CR37","unstructured":"Brogaard, L. R. et al. Gruppe B streptokokker\u2014early onset disease: Profylakse inklusiv GBS screening intrapartum (Danish guidelines). https:\/\/static1.squarespace.com\/static\/5467abcce4b056d72594db79\/t\/5ca102ba8165f5e47dc82473\/1554055869683\/Gruppe%2520B%2520streptokokker%2520-%2520Early%2520onset%2520disease.%2520Profylakse%2520inklusiv%2520GBS%2520screening%2520intrapartum.17.03.19.pdf (2019)."},{"key":"1092_CR38","unstructured":"Norsk gynekologisk forening (NGO). in (HDIR) Nasjonale faglige rettningslinjer, Helsedirektoratet (Norwegian guidelines), p. 33 (2009)."},{"key":"1092_CR39","unstructured":"Royal College of Obstetricians and Gynaecologists (RCOG). Prevention of Early Onset Neonatal Group B Streptococcal Disease; Green Top Guidelines 36 (RCOG, 2003)."},{"key":"1092_CR40","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1111\/j.1471-0528.2006.01086.x","volume":"113","author":"S Hakansson","year":"2006","unstructured":"Hakansson, S. & Kallen, K. Impact and risk factors for early-onset group B streptococcal morbidity: analysis of a national, population-based cohort in Sweden 1997\u20132001. BJOG 113, 1452\u20131458 (2006).","journal-title":"BJOG"},{"key":"1092_CR41","unstructured":"Waal, G. & Engedal, I. Intrapartum antibiotikaprofylakse ved terminf\u00f8dsler, f\u00f8deavdelingen. St. Olavs Hospital, 2004, Student thesis, NTNU (2008)."},{"key":"1092_CR42","unstructured":"Hajdu, A. Epidemiologisk og mikrobiologisk kartlegging av systemiske gruppe B streptokokk infeksjoner hos nyf\u00f8dte og spedbarn under tre m\u00e5neder i Norge, januar 2005\u2013juli 2006 (2007)."},{"key":"1092_CR43","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3389\/fimmu.2014.00519","volume":"5","author":"S Landwehr-Kenzel","year":"2014","unstructured":"Landwehr-Kenzel, S. & Henneke, P. Interaction of Streptococcus agalactiae and cellular innate immunity in colonization and disease. Front. Immunol. 5, 519 (2014).","journal-title":"Front. Immunol."},{"issue":"Suppl. 4","key":"1092_CR44","doi-asserted-by":"publisher","first-page":"D20","DOI":"10.1016\/j.vaccine.2012.11.056","volume":"31","author":"SJ Schrag","year":"2013","unstructured":"Schrag, S. J. & Verani, J. R. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine 31(Suppl. 4), D20\u2013D26 (2013).","journal-title":"Vaccine"},{"key":"1092_CR45","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1530\/ror.0.0040081","volume":"4","author":"F Saji","year":"1999","unstructured":"Saji, F., Samejima, Y., Kamiura, S. & Koyama, M. Dynamics of immunoglobulins at the feto-maternal interface. Rev. Reprod. 4, 81\u201389 (1999).","journal-title":"Rev. Reprod."},{"key":"1092_CR46","doi-asserted-by":"publisher","first-page":"e513","DOI":"10.1016\/j.cmi.2015.01.030","volume":"21","author":"G Kwatra","year":"2015","unstructured":"Kwatra, G. et al. Natural acquired humoral immunity against serotype-specific group B streptococcus rectovaginal colonization acquisition in pregnant women. Clin. Microbiol. Infect. 21, e513\u2013521 (2015).","journal-title":"Clin. Microbiol. Infect."},{"key":"1092_CR47","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1016\/j.vaccine.2015.12.072","volume":"34","author":"PT Heath","year":"2016","unstructured":"Heath, P. T. Status of vaccine research and development of vaccines for GBS. Vaccine 34, 2876\u20132879 (2016).","journal-title":"Vaccine"}],"updated-by":[{"DOI":"10.1038\/s41390-021-01887-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000}}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-1092-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-1092-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-1092-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T23:45:44Z","timestamp":1723333544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-1092-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,29]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1092"],"URL":"https:\/\/doi.org\/10.1038\/s41390-020-1092-2","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41390-021-01887-8","asserted-by":"object"}]},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,29]]},"assertion":[{"value":"10 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2021","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41390-021-01887-8","URL":"https:\/\/doi.org\/10.1038\/s41390-021-01887-8","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Parents of children with CP have provided written informed consent allowing their children to be registered in the CPRN and to link data to the MBRN, as well as to other Norwegian health registers. The Regional Committee for Medical and Health Research Ethics in Central Norway approved that an additional informed consent for this specific study was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}}]}}